View Larger Image Covishield, Covaxin get regular market nod By Mansukh Mandaviya|2022-02-01T14:33:00+05:30January 28, 2022|Media Coverages|Comments Off on Covishield, Covaxin get regular market nod Share This Story, Choose Your Platform! FacebookTwitterLinkedInWhatsApp About the Author: Mansukh Mandaviya Related Posts Creating a digital health ecosystem Gallery Creating a digital health ecosystem ‘Over 80% in the 15-18 Age Group Has Got 1st Jab’ Gallery ‘Over 80% in the 15-18 Age Group Has Got 1st Jab’ 80% in 15-18 age group have got 1st jab Gallery 80% in 15-18 age group have got 1st jab Ayushman Bharat Health Account app relaunched Gallery Ayushman Bharat Health Account app relaunched
